New data suggests the risk of blood clots from Astra-Zeneca is 1 in 60,000.
Ontario is going to pause first doses of the Oxford Astra-Zeneca vaccine over concerns around blood clots.
Chief Medical Officer of Health Dr. David Williams made the announcement during a press briefing this afternoon. New data suggests the risk of blood clots from Astra-Zeneca is higher then previously thought at 1 in 60,000.
This is not expected to impact the vaccine rollout in Ontario thanks to increased supply from Pfizer and Moderna.
The Province is currently reviewing data for second doses and it is possible those who got the first shot of Astra-Zeneca could end up with a second dose from Pfizer or Moderna. According to recent data, the risk of blood clots from the second dose of Astra-Zeneca is much smaller.
Dr. Williams did say anyone who already received the first dose of Astra-Zeneca did the right thing and this decision was made out of an abundance of caution. He notes the increased supply of Moderna and Pfizer helped make this an easier decision.

Dog Bite Investigation in Tillsonburg
Interview with the Warden - January 29th, 2026
Trevor Birtch Trial Daily Recap - Case 2
11 People Charged in Massive Drug Bust
Another Cold Warning for Oxford County
Chilly Charlie Returns on Monday
Khanna Shines a Light on Oxford County Superstars
WFD Responds to Structure Fire
WPS Appoints New Deputy Chief
TMMC Woodstock Begins Production of Sixth Gen RAV4
Oxford OPP Briefs - January 28th, 2026
More Weather Alerts for Oxford County
Thrive Oxford Honoured at ROMA
Tip Tuesday with the Oxford OPP - January 2026
Members Needed for Tillsonburg Housing Advisory Committee
UPDATE: Ottawa Approves Plan to Move Marineland's Whales and Dolphins
Over 200 Collisions Reported in West Region
Another Day of Bus Cancellations in Oxford
UPDATE: Environment Canada Issues Cold Warning
Last Call for Pizza for a Purpose Tickets
Comments
Add a comment